Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum) after intramuscular, oral and bath administration

Size: px
Start display at page:

Download "Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum) after intramuscular, oral and bath administration"

Transcription

1 J. vet. Pharmacol. Therap. 20, 124±128, PHARMACOKINETICS Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum) after intramuscular, oral and bath administration G. LEWBART* S. VADEN* J. DEEN{ C. MANAUGH* D. WHITT* A. DOI* T. SMITH* & K. FLAMMER* *Department of Companion Animal and Special Species Medicine, College of Veterinary Medicine and {Department of Food Animal and Equine Medicine, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina 27606, USA Ahed Bhed Ched Dhed Ref marker Fig marker Table marker Ref end Ref start Lewbart, G., Vaden, S., Deen, J., Manaugh, C., Whitt, D., Doi, A., Smith, T., Flammer K.. Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum) after intramuscular, oral and bath administration. J. vet. Pharmacol. Therap. 20, 124±128. The intramuscular (i.m.), oral (p.o.), and bath immersion disposition of enrofloxacin were evaluated following administration to a cultured population of red pacu. The half-life for enrofloxacin following i.m. administration was 28.9 h, considerably longer than values calculated for other animals such as dogs, birds, rabbits, and tortoises. The 4 h maximum concentration (C max )of 1.64 mg/ml following a single 5.0 mg/kg dosing easily exceeds the in vitro minimum inhibitory concentration (MIC) for 20 bacterial organisms known to infect fish. At 48 h post i.m. administration, the mean plasma enrofloxacin concentration was well above the MIC for most gram-negative fish pathogens. The gavage method of oral enrofloxacin administration produced a C max of 0.94 mg/ml at 6±8 h. This C max was well above the reported in vitro MIC. A bath immersion concentration of 2.5 mg/l for 5 h was used in this study. The C max of 0.17 mg/ml was noted on the 2 hour post-treatment plasma sample. Plasma concentrations of enrofloxacin exceeded published in vitro MIC's for most fish bacterial pathogens 72 h after treatment was concluded. Ciprofloxacin, an active metabolite of enrofloxacin, was detected and measured after all methods of drug administration. It is possible and practical to obtain therapeutic blood concentrations of enrofloxacin in the red pacu using p.o., i.m., and bath immersion administration. The i.m. route is the most predictable and results in the highest plasma concentrations of the drug. (Paper received 30 November 1995; accepted for publication 21 July 1996) G.A. Lewbart, Department of Companion Animal and Special Species Medicine, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street, Raleigh, North Carolina 27606, USA. INTRODUCTION Keeping and breeding of tropical fishes is a popular hobby throughout the world. Over sixty million dollars worth of tropical freshwater fishes are raised annually on farms in Florida and this represents only a fraction of the entire industry (Florida Agricultural Statistics Service, 1994). For many years veterinarians have had little impact on the pet fish hobby (Purchase et al., 1993; Smith, 1994). Most sick fish are treated by aquaculturists, hobbyists, and pet store clerks with chemotherapeutics which have been purchased over the counter. In an effort to curb the flow of pet fish medications to the food fish aquaculture industry in the United States, the FDA is currently considering placing restrictions on the wide availability of these compounds. If these regulations are imposed, many more veterinarians will become more involved in treating ornamental fishes whether they be client owned pets or fishes at the retail, wholesale, and aquaculture levels of the industry. The fluoroquinolone antimicrobials have attracted much interest in the past ten years. They provide broad spectrum antibacterial activity and are particularly active against gramnegative pathogens (Neer, 1988; Vancutsem et al., 1990). Enrofloxacin kills bacteria at low concentrations by interrupting the normal coiling of DNA within the nucleus through inhibition of DNA-gyrase activity. This unique mechanism of action makes enrofloxacin effective against bacteria that are resistant to other antibiotics (Sheer, 1987). Results of pharmacokinetic studies of enrofloxacin in domestic animals (cats, cattle, chickens, dogs, pigeons, pigs, rabbits, turkeys) and exotic species (African grey parrots, Florida gopher tortoises, radiated tortoises) have been reported (Walker et al., 1989; Dorrestein & Verburg, 1990; Flammer et al., 1990; Vancutsem et al., 1990; Flammer et al., 1991; Cabanes et al., 1992; Prezant et al., 1994; Raphael et al., 1994). The in vitro antimicrobial activity and clinical efficacy of enrofloxacin against gram-negative bacterial pathogens of ornamental and 124 #1997 Blackwell Science Ltd

2 Enrofloxacin in red pacu 125 food fishes have also been reported (Barnes et al., 1990; Reimlinger et al., 1990; Dalsgaard & Bjerregaard, 1991; Martinsen et al., 1992; Stoffregen et al., 1993). Several related papers discuss earlier quinolones, oxolinic and nalidixic acid, but do not describe pharmacokinetics of these compounds in fishes (Austin et al., 1983; Hastings & McKay, 1987; Stamm, 1989; Tsoumas et al., 1989; Bowser & House, 1990). A single paper on enrofloxacin pharmacokinetics in fishes exists (Bowser et al., 1992) and it deals with a salmonid, the rainbow trout (Oncorhynchus mykiss). The objectives of this study were to determine the maximum serum concentrations, elimination half-life, and relative bioavailability of enrofloxacin in the red pacu following intramuscular (i.m.), oral (p.o.), and bath administration. Results of this research can be compared with existing information on the clinical efficacy of this drug and will provide a foundation for determining p.o., i.m., and bath immersion treatment protocols for enrofloxacin in ornamental fishes. This data can be correlated with in vitro minimum inhibitory concentration (MIC) for given bacterial pathogens in order to design safe and effective clinical treatment protocols. MATERIALS AND METHODS Animals We used 88 red pacu for the study. Fish were of uniform age and size (& 8 months old and weighing 35±50 g each). All animals were quarantined and acclimatised to their environment for 30 days prior to the study. Fish were maintained in L aquariums which all shared a common water supply via a recirculating system. Each aquarium housed four research fish. Important water quality parameters such as temperature (258C), ph (7.2), total alkalinity (51.0 mg/l), and specific gravity (1.000) were constant and tightly controlled. Experimental design Intramuscular and oral dosing. All fish were weighed immediately prior to dosing. Eighty-eight fish were randomly divided into two groups; a two-way cross-over design was employed. Fish in group A received 5.0 mg/kg enrofloxacin i.m. while those in group B received the same dose p.o. (via gavage tube). The i.m. route was essential to this study since it is the only one which theoretically approximated 100% bioavailability of the drug. Three treated fish and one control fish were kept in each tank. Controls were given sterile water and fish were individually identified by clipping pectoral and pelvic fins. Approximately 0.4 ml of blood was taken from the caudal vein from three fish in each group and one control fish at the following times post drug administration: 0, 2, 4, 6, 8, 12, 24, 36, 48, 72, 96, and 120 h. Each fish was sampled prior to dosing and once per experiment. Following a 21-day washout period, fish in group B received 5.0 mg/kg enrofloxacin i.m. while those in group A received the same dose p.o.. Sampling was performed as previously described. Bath administration Following a 21-day washout period (O'Grady et al., 1988) 60 fish were divided into 10 aquariums. Fifty fish were given enrofloxacin by immersing the fish in water containing 2.5 mg enrofloxacin/l of water for 5 h. Ten fish (one per group) served as controls and were immersed in clean, unmedicated water. Therefore, each tank housed five treated fish and one control fish. Approximately 0.4 ml of blood was taken from the caudal vein from each group before treatment and at the following times post-treatment: 2, 4, and 8 h, and 1, 3, 6, 10, 14, 17, and 21 days. Sample and data analysis Plasma was immediately separated from blood and stored at 7708C until sample analysis was performed. All samples were analyzed by high performance liquid chromatography (HPLC) using modifications of previously published methods. The HPLC system consisted of a LC-10AD pump, SPD-10AV ultraviolet detector, SIL±9 A autosampler (Schimadzu Scientific Instruments, Columbia, MD). Samples were injected onto a guard column (Zorbax C 18 4 mm cm, MAC-MOD Analytical Inc., Chadds Ford, PA). Chromatographic separations were performed on a Zorbax SB-C 8 column (4.6 mm 6 15 cm, MAC-MOD Analytical, Chadds Ford, PA). The mobile phase was 86% phosphoric acid (HPLC grade chemicals, Fisher Scientific, Pittsburgh, PA). Elution was isocratic (1 ml/min) at room temperature; the detection wavelength was 279 nm. Stock solutions of standards were made by reconstituting powdered enrofloxacin, ciprofloxacin (Miles Inc., Shawnee Mission, Kansas) or ofloxacin (Sigma Chemicals Co., St. Louis, MO) in methanol (1 mg/ml). Standards were further diluted in mobile phase and stored at 48C for up to 1 month. To polypropylene tubes containing 200 ml of plasma, were added 25 ml of internal standard (10 mg ofloxacin/ml) and 0.5 ml of methanol. The samples were mixed by vortexing for 20 s, placed on ice for 15 min, and then centrifuged at a high rate of speed for 10 min. The supernatant (750 ml) was transferred to centrifuge tubes. Dichloromethane (6 ml, Fisher Scientific, Pittsburgh, PA) was added and the contents mixed by vortexing for 20 s followed by centrifugation at 1,000 g for 10 min. After discarding the aqueous phase, the organic phase was transferred to a clean glass tube and evaporated to dryness at 408C under a steady stream of nitrogen. The residue was then reconstituted in 50 ml of mobile phase; 50 ml of which was injected into the column for HPLC analysis. Retention times of ofloxacin, ciprofloxacin, and enrofloxacin were 5.7, 6.9 and 9.0 min, respectively. Standard curves of enrofloxacin:ofloxacin and ciprofloxacin:ofloxacin (determined by chromatographic areas) were used to calculate enrofloxacin and ciprofloxacin concentrations. For both ciprofloxacin and enrofloxacin, the limit of detection was 5 ng/ml and the range of linearity was 5 ng/ml to 1 mg/ml. The coefficient of variations for enrofloxacin and ciprofloxacin were 8.1% and 9.3%, respectively. The mean recoveries of enrofloxacin, ciprofloxacin and ofloxacin were 92%, 76% and 100%, respectively.

3 126 G. Lewbart et al. Pharmacokinetic calculations A non-compartmental model analysis using Quattro Pro TM (Borland, Scotts Valley, CA) was used to generate pharmacokinetic data. The mean concentration at each time point was used for calculation of elimination half-life, C max, and area under the time±concentration curve (AUC). The AUC was calculated using the trapezoidal rule. Relative bioavailability of i.m. and p.o. routes of drug administration were calculated using AUC data. Half-life values were calculated from linear regression of log transformed data. Data from the bath experiment was used to determine the duration of time which serum levels of enrofloxacin greater than the MIC for most susceptible fish pathogens were maintained. RESULTS Intramuscular study Figure 1 demonstrates the plasma concentration±time profile for enrofloxacin following i.m. administration. The corresponding pharmacokinetic parameters are listed in Table 1. The mean C max of enrofloxacin was 1.64 (+ 0.92) mg/ml obtained at 4 h following injection and declined to 0.2 (+ 0.09) mg/ml by 96 h. The elimination half-life for enrofloxacin was 28.9 h. Ciprofloxacin, a major metabolite of enrofloxacin, was present in the plasma at much lower concentrations than enrofloxacin. The mean C max of ciprofloxacin was 0.05 (+ 0.01) mg/ml at 4 h and declined to ( ) mg/ml by 96 h (Table 1). The elimination half-life for ciprofloxacin was 53 h. Oral study Figure 2 demonstrates the plasma concentration±time profile for enrofloxacin following oral administration. The corresponding pharmacokinetic parameters are listed in Table 1. The mean C max of enrofloxacin was 0.8 (+ 1.17) mg/ml obtained at 36 h following gavage and declined to 0.19 (+ 0.08) mg/ml by 120 h. The mean C max of ciprofloxacin was 0.02 ( ) mg/ml at 36 h and declined to ( ) by 96 h (Table 1). Bath administration study The plasma concentration±time profile following 5 hour bath administration of enrofloxacin is demonstrated in Fig. 3. The Fig. 1. Mean plasma concentrations of enrofloxacin (solid line) and ciprofloxacin (dotted line) in red pacu following i.m. administration of enrofloxacin at a dose of 5.0 mg/kg body weight. Fig. 2. Mean plasma concentrations of enrofloxacin (solid line) and ciprofloxacin (dotted line) in red pacu following p.o. administration of enrofloxacin at a dose of 5.0 mg/kg body weight. Intramuscular Oral ENRO CIPRO ENRO CIPRO AUC (mg.h/ml) AUMC (mg.h 2 /ml) 1, , t 1/2 (h) Relative F (%) 57.2 C max (mg/ml)* T max Table 1. Mean pharmacokinetic values calculated for enrofloxacin and ciprofloxacin following i.m. and p.o. administration of 5.0 mg/kg enrofloxacin to red pacu *Mean (SD)

4 Enrofloxacin in red pacu 127 Fig. 3. Mean plasma concentrations of enrofloxacin (solid line) and ciprofloxacin (dotted line) in red pacu following bath administration of enrofloxacin for a 5 hour duration. mean C max of enrofloxacin was 0.17(+ 0.04) mg/ml obtained at 2 h following removal from the bath and declined to (+ 0.02) mg/ml by 72 h. No detectable levels of enrofloxacin existed at 144 h post bath administration. The mean C max of ciprofloxacin was ( ) mg/ml at 2 h and declined to ( ) by 24 h. DISCUSSION Three different routes of enrofloxacin administration were analysed in order to determine selected pharmacokinetic parameters for enrofloxacin in the red pacu. All three regimens are used frequently when treating ornamental fishes. The half-life for intramuscularly administered enrofloxacin was considerably longer than values calculated for other animals such as dogs, birds, rabbits, and tortoises (Sheer, 1987; Flammer et al. 1991; Cabanes et al., 1992; Prezant et al., 1994; Raphael et al., 1994). Among these animals, the gopher tortoise study (Prezant et al., 1994) most closely approximated the results of the pacu study with an elimination half-life of 23.1 h and a C max of 2.4 mg/ml. The gopher tortoises in the study were given the same 5 mg/kg dose as the pacu. In rainbow trout given 5 mg/kg enrofloxacin i.v. (Bowser et al., 1992), the elimination half-life determined by a bioassay technique was 24.4 h, a value close to that obtained in the i.m. pacu study. In many species of animals, enrofloxacin is de-ethylated to ciprofloxacin, the primary metabolite of enrofloxacin (Tyczkowska et al., 1989). Both of these quinolone compounds work similarly and are active against many gram-negative organisms raising the possibility that the presence of both drugs supplies some benefit to the patient (Flammer et al., 1991). While this study does not address a specific bacterial pathogen, the existence of in vitro MIC data supports the statement that effective plasma concentrations of enrofloxacin can be obtained in the red pacu after a single 5 mg/kg i.m. injection. The 4 h C max of 1.64 mg/ml easily exceeds the in vitro MIC for 20 bacterial organisms known to infect fish (Bowser & House, 1990). For the majority of these organisms, the red pacu C max was more than 10 times greater than the MIC. These MIC results support data presented in other studies (Vancutsem et al., 1990) on gram-negative pathogens of reptiles and higher vertebrates. At 48 h post i.m. enrofloxacin administration, the mean plasma enrofloxacin concentration was 0.33 mg/ml. This concentration is well above the MIC for most gram-negative fish pathogens. Therefore, a dosing regimen of 5 mg/kg i.m. every 48 h is recommended in the red pacu. The gavage method of oral enrofloxacin administration produced a much lower mean C max than the i.m. route and three distinct plasma peaks were noted (8, 24, and 36 h) and are evident in Fig. 2. These results show some similarities with oral enrofloxacin dosing via feed in rainbow trout. In the trout (Bowser et al., 1992) a C max of 0.94 mg/ml at 6±8 h was observed and the authors noted that the 24- and 36-h serum levels were only slightly lower that the 6±8-h value. It is possible that there is entero-hepatic recirculation of enrofloxacin resulting in delayed peaks or that there is intraspecies variability in rate of absorption. The C max value for the oral enrofloxacin study was well above the previously reported in vitro MIC values. Inherent problems exist when bath immersion is elected as a route of antibiotic administration in fish. A broad spectrum quinolone such as enrofloxacin will likely compromise the biological filter by killing or reducing numbers of the nitrifying bacteria, Nitrosomonas and Nitrobacter. Antibiotics in the water are also difficult to dispose of and can become an environmental contaminant. A third consideration, largely dependent on the volume of water used in the bath, is the expense of this type of treatment due to the large amounts of antibiotic required. However, when fish are too small for parenteral drug administration or are anorexic, bath immersion may be the only treatment option. Reimlinger et al. (1990) reports the effects of enrofloxacin in the water on five species of ornamental fishes. The results of their study led them to recommend a 30 mg/l 5-h bath. Their study included only subjective observations of how fish responded to bath treatments ranging in concentration from 10 mg/l to 600 mg/l. No blood or tissue drug concentration data were reported. We empirically selected a bath immersion concentration of 2.5 mg/l for 5 h in this study. Our results support reports in the pet fish industry that enrofloxacin is effective when administered as a bath and is absorbed into the bloodstream from the water. Since freshwater fish do not drink, the most likely point of absorption during a bath treatment is across the high surface area gill epithelium. The C max of 0.17 mg/ml was noted on the 2-h post-treatment plasma sample. Plasma levels of enrofloxacin exceeded published in vitro MIC's for most fish bacterial pathogens 72 h after treatment was concluded. A 5-h bath of

5 128 G. Lewbart et al. 2.5 mg/l enrofloxacin administered every 24±48 h would be sufficient to produce adequate blood levels of enrofloxacin in the red pacu. This study indicates that it is possible to obtain therapeutic blood concentrations of enrofloxacin in the red pacu using p.o., i.m., and bath immersion administration. The i.m. route is the most predictable and results in the highest plasma concentrations of the drug. The variability in the p.o. gavage method is most likely due to inaccurate dosing due to regurgitation which likely occurred to some extent. We were unable to quantify this finding. Bath immersion, the dosing method used most frequently by ornamental fish enthusiasts, does produce adequate plasma levels when dosed at 2.5 mg/l for 5 h. ACKNOWLEDGMENTS This study was funded by the state of North Carolina. The authors would like to add a special thanks to Stan Dunston and Maureen Trogdon for their help in this study. REFERENCES Austin, B., Rayment, J. & Alderman, D.J. (1983) Control of furunculosis by oxolinic acid. Aquaculture, 31, 101±108. Barnes, A.C., Lewin, C.S., Hastings, T.S. & Amyes, S.G.B. (1990) In vitro activities of 4-quinolones against the fish pathogen Aeromonas salmonicida. Antimicrobial Agents and Chemotherapy, 34, 1819±1820. Bowser, P.R., Wooster, G.A., St Leger, J. & Babish, J.G. (1992) Pharmacokinetics of enrofloxacin in fingerling rainbow trout (Oncorhynchus mykiss). Journal of Veterinary Pharmacology and Therapeutics, 15, 62±71. Bowser, P.R. & M. House. (1990) In vitro sensitivity of some fish pathogens to the quinolones naladixic acid and oxolinic acid and the fluoroquinolone enrofloxacin. Bulletin of the European Association of Fish Pathologists, 10, 48±49. Cabanes, A., Arboix, M., Anton, J.M.G. & Reig, F. (1992) Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. American Journal of Veterinary Research, 53, 2090±2093. Dalsgaard, I. & Bjerregaard, J. (1991) Enrofloxacin as an antibiotic in fish. Acta Veterinaria Scandinavica Supplement, 87, 300±302. Dorrestein, G.M. & Verburg, E. (1990) Pharmacokinetics of enrofloxacin in homing pigeons. In: Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals. pp. 27±30. University of Veterinary Scice- Unipharma Co., Budapest, Hungary. Flammer, K., Aucoin, D.P. & Whitt, D.A. (1991) Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses. Journal of Veterinary Pharmacology and Therapeutics, 14, 359±366. Flammer, K., Aucoin, D.P., Whitt, D.A. & Prus, S.A. (1990) Plasma concentrations of enrofloxacin in African grey parrots treated with medicated water. Avian Diseases, 34, 1017±1022. Florida Agricultural Statistics Service. (1994) Aquaculture Magazine, 20, 46±54. Hastings, T.S. & McKay, A. (1987) Resistance of Aeromonas salmonicida to oxolinic acid. Aquaculture, 61, 165±171. Martinsen, B., Oppegaard, H., Wichstrom, R. & Myhr, E. (1992) Temperature-dependent in vitro antimicrobial activity of four 4- quinolones and oxytetracycline against bacteria pathogenic to fish. Antimicrobial Agents and Chemotherapy, 36, 1738±1743. Neer, T.M. (1988) Clinical pharmacologic features of fluoroquinolone antimicrobial drugs. Journal of the American Veterinary Medical Association, 193, 577±580. O'Grady, P., Moloney, M. & Smith, P.R. (1988) Bath administration of the quinolone antibiotic flumequine to brown trout, Salmo trutta, and Atlantic salmon S. salar. Diseases of Aquatic Organisms, 4, 27±33. Prezant, R.M., Isaza, R. & Jacobson, E.R. (1994) Plasma concentrations and disposition kinetics of enrofloxacin in gopher tortoises (Gopherus polyphemus). Journal of Zoo and Wildlife Medicine, 25, 82±87. Purchase, H.G., Gloyd, J. & Pitts, J.L. (1993) Opportunities for veterinarians in aquaculture. Journal of the American Veterinary Medical Association, 202, 734±737. Raphael, B.L., Papich, M. & Cook, R.A. (1994) Pharmacokinetics of enrofloxacin after a single intramuscular injection in Indian star tortoises (Geochelone elegans). Journal of Zoo and Wildlife Medicine, 25, 88±94. Reimlinger, M., Hoffman, R., Pfeil-Putzien, C. & Scheinert, P. (1990) Enrofloxacin, a new drug for ornamental fish. TieraÈrtzliche Praxis, 18, 653±657. Sheer, M. (1987) Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Veterinary Medical Review, 2, 104±118. Smith, C.A. (1994) Pet fish medicine offers new challenges. Journal of the American Veterinary Medical Association, 205, 1267±1271. Stamm, J.M. (1989) In vitro resistance by fish pathogens to aquacultural antibacterials, including the quinolones difloxacin (A-56619) and sarafloxacin (A-56620). Journal of Aquatic Animal Health, 1, 135± 141. Stoffregen, D.A., Chako, A.J., Backman, S. & Babish, J.G. (1993) Successful therapy of furunculosis in Atlantic salmon, Salmo salar, L., using the fluoroquinolone antimicrobial agent enrofloxacin. Journal of Fish Diseases, 16, 219±228. Tyczkowska, K., Hedeen, K.M., Aucoin, D.P. & Aronson, A.L. (1989) High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue. Journal of Chromatography, 493, 337±346. Tsoumas, A., Alderman, D.J. & Rodgers, C.J. (1989) Aeromonas salmonicida: development of resistance to 4-quinolone antimicrobials. Journal of Fish Diseases, 12, 493±507. Vancutsem, P.M., Babish, J.G. & Schwark, W.S. (1990) The fluoroquinolone antimicrobials: Structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Veterinarian, 80, 173±186. Walker, R.D., Stein, G.E., Hauptman, J.G. & MacDonald, K.H. (1989) Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs, American Journal of Veterinary Research, 53, 2315± 2319.

Pharmacokinetics of Enrofloxacin in Koi Carp (Cyprinus carpio) after Various Routes of Administration

Pharmacokinetics of Enrofloxacin in Koi Carp (Cyprinus carpio) after Various Routes of Administration Kasetsart J. (Nat. Sci.) 41 : 62-68 (2007) Pharmacokinetics of Enrofloxacin in Koi Carp (Cyprinus carpio) after Various Routes of Administration Pareeya Udomkusonsri 1 *, Surapong Arthitvong 2, Narumol

More information

Received 3 June 1994/Returned for modification 14 October 1994/Accepted 3 March 1995

Received 3 June 1994/Returned for modification 14 October 1994/Accepted 3 March 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1995, p. 1059 1064 Vol. 39, No. 5 0066-4804/95/$04.00 0 Copyright 1995, American Society for Microbiology Comparative Single-Dose Pharmacokinetics of Four Quinolones,

More information

Received 3 June 1994/Returned for modification 14 October 1994/Accepted 3 March 1995

Received 3 June 1994/Returned for modification 14 October 1994/Accepted 3 March 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1995, p. 1059 1064 Vol. 39, No. 5 0066-4804/95/$04.00 0 Copyright 1995, American Society for Microbiology Comparative Single-Dose Pharmacokinetics of Four Quinolones,

More information

Concentration of Enrofloxacin Residue from Tilapia (Oreochromis niloticus) Muscular That Infected by Aeromonas salmonicida

Concentration of Enrofloxacin Residue from Tilapia (Oreochromis niloticus) Muscular That Infected by Aeromonas salmonicida Journal of Agricultural Science and Technology A 4 (2014) 750-754 Earlier title: Journal of Agricultural Science and Technology, ISSN 1939-1250 doi: 10.17265/2161-6256/2014.09.005 D DAVID PUBLISHING Concentration

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/389/98-FINAL July 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS ENROFLOXACIN (extension to

More information

Ultra-Fast Analysis of Contaminant Residue from Propolis by LC/MS/MS Using SPE

Ultra-Fast Analysis of Contaminant Residue from Propolis by LC/MS/MS Using SPE Ultra-Fast Analysis of Contaminant Residue from Propolis by LC/MS/MS Using SPE Matthew Trass, Philip J. Koerner and Jeff Layne Phenomenex, Inc., 411 Madrid Ave.,Torrance, CA 90501 USA PO88780811_L_2 Introduction

More information

Pharmacokinetics of the Bovine Formulation of Enrofloxacin (Baytril 100) in Horses

Pharmacokinetics of the Bovine Formulation of Enrofloxacin (Baytril 100) in Horses C. Boeckh, C. Buchanan, A. Boeckh, S. Wilkie, C. Davis, T. Buchanan, and D. Boothe Pharmacokinetics of the Bovine Formulation of Enrofloxacin (Baytril 100) in Horses Christine Boeckh, DVM, MS a Charles

More information

Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys. Géza Sárközy

Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys. Géza Sárközy Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys Géza Sárközy Department of Pharmacology and Toxicology Faculty of Veterinary Science Szent István University

More information

SZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science

SZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science SZENT ISTVÁN UNIVERSITY Doctoral School of Veterinary Science Comparative pharmacokinetics of the amoxicillinclavulanic acid combination in broiler chickens and turkeys, susceptibility and stability tests

More information

Baytril 100 (enrofloxacin) Injectable is FDA-approved for BRD control (metaphylaxis) in high-risk cattle.

Baytril 100 (enrofloxacin) Injectable is FDA-approved for BRD control (metaphylaxis) in high-risk cattle. Baytril 100 (enrofloxacin) Injectable is FDA-approved for BRD control (metaphylaxis) in high-risk cattle. Whether controlling or treating BRD, it s important to kill bacteria to let the calf s immune system

More information

Detection of residues of quinolones in milk

Detection of residues of quinolones in milk Food Safety and Monitoring of Safety Aspects 77 Detection of residues of quinolones in milk Gertraud Suhren and P. Hammer Federal Dairy Research Centre, Institute for Hygiene, Hermann-Weigmann-Str. 1,

More information

You can lock the gate for seven days, but you can t stop Baytril 100 (enrofloxacin) Injectable.

You can lock the gate for seven days, but you can t stop Baytril 100 (enrofloxacin) Injectable. You can lock the gate for seven days, but you can t stop Baytril 100 (enrofloxacin) Injectable. Baytril 100 (enrofloxacin) Injectable field trial investigates the lock the gate BRD treatment regimen. Often,

More information

Kinetic Studies of Enrofloxacin after Intravenous Administration in Yak

Kinetic Studies of Enrofloxacin after Intravenous Administration in Yak Kinetic Studies of Enrofloxacin after Intravenous Administration in Yak Sanjib Khargharia*, Chandana Choudhury Barua**, H.N. Khanikar**, P. Mohan** * Clintox Bioservices, S.P. Biotech Park, Shameerpet,

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND

More information

Enrofloxacin pharmacokinetics in the European cuttlefish, Sepia officinalis, after a single i.v. injection and bath administration

Enrofloxacin pharmacokinetics in the European cuttlefish, Sepia officinalis, after a single i.v. injection and bath administration J. vet. Pharmacol. Therap. 28, 433 439, 2005. ANTIINFECTANTS Enrofloxacin pharmacokinetics in the European cuttlefish, Sepia officinalis, after a single i.v. injection and bath administration S. R. GORE*

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE European Medicines Agency Veterinary Medicines and Inspections EMEA/CVMP/211249/2005-FINAL July 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE DIHYDROSTREPTOMYCIN (Extrapolation to all ruminants)

More information

to compare the potencies of oxolinic acid, three different Bacterial strains. Ninety-two bacterial strains representing

to compare the potencies of oxolinic acid, three different Bacterial strains. Ninety-two bacterial strains representing ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1992, p. 1738-1743 0066-4804/92/081738-06$02.00/0 Copyright 1992, American Society for Microbiology Vol. 36, No. 8 Temperature-Dependent In Vitro Antimicrobial

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrocare 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats (UK, IE, FR) Floxadil 50 mg/ml Solution for Injection

More information

Compliance. Should you have any questions, please contact Praveen Pabba, Ph.D., ( or

Compliance. Should you have any questions, please contact Praveen Pabba, Ph.D., ( or Doxycycline Hyclate Delayed-Release Tablets Type of Posting Revision Bulletin Posting Date 28 Jul 2017 Official Date 01 Aug 2017 Expert Committee Chemical Medicines Monographs 1 Reason for Revision Compliance

More information

single intravenous and oral doses and after 14 repeated oral

single intravenous and oral doses and after 14 repeated oral Br. J. clin. Pharmac. (1986), 22, 21-25 The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily J. K. FAULKNER

More information

Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified)

Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified) Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified) (Note: many chemicals have been used at one time or another to combat bacterial disease in koi. We have attempted

More information

European Public MRL assessment report (EPMAR)

European Public MRL assessment report (EPMAR) 18 March 2016 EMA/CVMP/619817/2015 Committee for Medicinal Products for Veterinary Use European Public MRL assessment report (EPMAR) Gentamicin (all mammalian food producing species and fin fish) On 3

More information

Oral pharmacokinetics of fenbendazole in llamas, South American Camelids

Oral pharmacokinetics of fenbendazole in llamas, South American Camelids Small Ruminant Research 37 (2000) 209±214 Oral pharmacokinetics of fenbendazole in llamas, South American Camelids Earnest Beier III a, Terry W. Lehenbauer b, Subbiah Sangiah a,* a Department of Anatomy,

More information

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES PHARMACOKINETIC INTERACTION OF MOXIFLOXACIN AND

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES PHARMACOKINETIC INTERACTION OF MOXIFLOXACIN AND PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES PHARMACOKINETIC INTERACTION OF MOXIFLOXACIN AND MELOXICAM FOLLOWING INTRAMUSCULAR ADMINISTRATION IN RATS KA Sadariya, AK Gothi,

More information

EXCEDE Sterile Suspension

EXCEDE Sterile Suspension VIAL LABEL MAIN PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS FOR ANIMAL TREATMENT ONLY EXCEDE Sterile Suspension 200 mg/ml CEFTIOFUR as Ceftiofur Crystalline Free

More information

Quantification of Chloramphenicol in Chicken Using Xevo TQD with RADAR Technology

Quantification of Chloramphenicol in Chicken Using Xevo TQD with RADAR Technology Quantification of Chloramphenicol in Chicken Using Xevo TQD with RADAR Technology Dimple Shah, Marian Twohig, and Jennifer A. Burgess Waters Corporation, Milford, MA, U.S.A. A P P L I C AT ION B E N E

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Marbocare 20 mg/ml solution for injection for cattle and pigs (UK, IE, FR) Odimar 20 mg/ml solution for injection for cattle

More information

Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows

Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows J. vet. Pharmacol. Therap. 21, 209±213, 1998. PHARMACOKINETICS Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows M. SHEM-TOV* O. RAV-HON{ G. ZIV{} E. LAVI A. GLICKMAN}

More information

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018)

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018) February 2018 Draft for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft

More information

European public MRL assessment report (EPMAR)

European public MRL assessment report (EPMAR) 15 January 2013 EMA/CVMP/914694/2011 Committee for Medicinal Products for Veterinary Use (CVMP) European public MRL assessment report (EPMAR) Fenbendazole (extension to chicken and extrapolation to all

More information

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry

More information

DISPOSITION STUDY OF MELOXICAM ALONE AND ALONG WITH ENROFLOXACIN IN MALE BUFFALO CALVES AFTER INTRAVENOUS ROUTE

DISPOSITION STUDY OF MELOXICAM ALONE AND ALONG WITH ENROFLOXACIN IN MALE BUFFALO CALVES AFTER INTRAVENOUS ROUTE Wayamba Journal of Animal Science ISSN: 2012-578X; P322 - P326, 2012 First Submitted May 04, 2012; Number 1337248676 DISPOSITION STUDY OF MELOXICAM ALONE AND ALONG WITH ENROFLOXACIN IN MALE BUFFALO CALVES

More information

IJCBS, 10(2016): International Journal of Chemical and Biochemical Sciences (ISSN )

IJCBS, 10(2016): International Journal of Chemical and Biochemical Sciences (ISSN ) IJCBS, 10(2016):10-15 International Journal of Chemical and Biochemical Sciences (ISSN 2226-9614) Journal Home page: www.iscientific.org/journal.html International Scientific Organization Quantification

More information

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED

More information

SELECT NEWS. Florfenicol Monograph: Injectable & Oral Therapy for Swine

SELECT NEWS. Florfenicol Monograph: Injectable & Oral Therapy for Swine SELECT NEWS Florfenicol Monograph: Injectable & Oral Therapy for Swine Did you know that? Florfenicol is one of the most powerful antibiotics currently available in veterinary medicine with one of the

More information

ANTIBIOTICS IN PLASMA

ANTIBIOTICS IN PLASMA by LC/MS Code LC79010 (Daptomycin, Vancomycin, Streptomycin, Linezolid, Levofloxacin, Ciprofloxacin, Gentamicin, Amikacin, Teicoplanin) INTRODUCTION Technically it defines "antibiotic" a substance of natural

More information

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MARBOCYL 10%, solution for injection for cattle and swine 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Marbofloxacin...100.0

More information

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One g contains:

More information

Pharmacokinetics of Amoxicillin/Clavulanic Acid Combination after Oral Administration of New Suspension Formulations in Human Volunteers

Pharmacokinetics of Amoxicillin/Clavulanic Acid Combination after Oral Administration of New Suspension Formulations in Human Volunteers R Iranian Journal of Pharmaceutical Sciences Summer 2006: 2(3): 129-136 www.ijps.ir Original Article Pharmacokinetics of Amoxicillin/Clavulanic Acid Combination after Oral Administration of New Suspension

More information

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Linco-Sol 400 mg/g powder for use in drinking water for pigs and chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active

More information

THE STABILITY OF E1VROFLOXA CIN University Undergraduate Research Fellow. A Senior Thesis. Texas ASM University.

THE STABILITY OF E1VROFLOXA CIN University Undergraduate Research Fellow. A Senior Thesis. Texas ASM University. THE STABILITY OF E1VROFLOXA CIN A Senior Thesis By Meagan A. Dodge 1997-98 University Undergraduate Research Fellow Texas ASM University Group: Biology THE STABILITY OF ENROFLOXACIN MEAGANA, DODGE Submitted

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS European Medicines Agency Veterinary Medicines and Inspections London, 12 November 2007 EMEA/CVMP/SAGAM/383441/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY

More information

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

1. NAME OF THE VETERINARY MEDICINAL PRODUCT Summary of Prodcuct Characteristics 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrox Max 100 mg/ml Solution for Injection for Cattle and Pigs Enroxal Max 100 mg/ml Solution for Injection for Cattle and

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS [Version 8, 10/2012] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS (Based on the current SPC of the reference product Baytril RSI 100 mg/ml Injektionslösung für Rinder und Schweine) 1 1. NAME OF THE VETERINARY

More information

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER 1. NAME OF THE VETERINARY MEDICINAL PRODUCT FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:

More information

Rapid LC-MS/MS Method for the Analysis of Fipronil and Amitraz Insecticides and Associated Metabolites in Egg and Other Poultry Products

Rapid LC-MS/MS Method for the Analysis of Fipronil and Amitraz Insecticides and Associated Metabolites in Egg and Other Poultry Products Rapid LC-MS/MS Method for the Analysis of Fipronil and Amitraz Insecticides and Associated Metabolites in Egg and Other Poultry Products Ashley Sage 1, Jianru Stahl-Zeng 2, Jason Causon 1, Mike Whitmore

More information

Research Article Disposition Kinetic of Moxifloxacin following Intravenous, Intramuscular, and Subcutaneous Administration in Goats

Research Article Disposition Kinetic of Moxifloxacin following Intravenous, Intramuscular, and Subcutaneous Administration in Goats International Scholarly Research Network ISRN Veterinary Science Volume 2011, Article ID 584342, 5 pages doi:10.5402/2011/584342 Research Article Disposition Kinetic of Moxifloxacin following Intravenous,

More information

Determination of Benzimidazole Residues in Animal Tissue by Ultra High Performance Liquid Chromatography Tandem Mass Spectrometry

Determination of Benzimidazole Residues in Animal Tissue by Ultra High Performance Liquid Chromatography Tandem Mass Spectrometry PO-CON1472E Determination of Benzimidazole Residues in Animal Tissue by Ultra High Performance Liquid Chromatography Tandem ASMS 14 TP 21 Yin Huo, Jinting Yao, Changkun Li, Taohong Huang, Shin-ichi Kawano,

More information

Fluoroquinolones ELISA KIT

Fluoroquinolones ELISA KIT Fluoroquinolones ELISA KIT Cat. No.:DEIA6883 Pkg.Size:96T Intended use The Fluoroquinolones ELISA KIT is an immunoassay for the detection of Fluoroquinolones in contaminated samples including water, fish

More information

LEVOFLOXACIN RESIDUES IN CHICKEN MEAT AND GIBLETS

LEVOFLOXACIN RESIDUES IN CHICKEN MEAT AND GIBLETS Bulgarian Journal of Veterinary Medicine (2013), 16, Suppl. 1, 216 219 LEVOFLOXACIN RESIDUES IN CHICKEN MEAT AND GIBLETS R. KYUCHUKOVA 1, V. URUMOVA 2, M. LYUTSKANOV 2, V. PETROV 2 & A. PAVLOV 1 1 Department

More information

Multi-residue Method II for Veterinary Drugs by HPLC (Animal and Fishery Products)

Multi-residue Method II for Veterinary Drugs by HPLC (Animal and Fishery Products) Multi-residue Method II for Veterinary Drugs by HPLC (Animal and Fishery Products) 1. Analytes See Table 8. 2. Instruments High performance liquid chromatograph-photodiode array detector (HPLC-DAD) High

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Amfipen LA 100 mg/ml suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Each ml contains:

More information

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,

More information

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere

More information

Allometric Analysis of Oxolinic Acid, Flumequine and Enrofloxacin in Fish

Allometric Analysis of Oxolinic Acid, Flumequine and Enrofloxacin in Fish World Applied Sciences Journal 24 (2): 234-239, 2013 ISSN 1818-4952 IDOSI Publications, 2013 DOI: 10.5829/idosi.wasj.2013.24.02.836 Allometric Analysis of Oxolinic Acid, Flumequine and Enrofloxacin in

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology Unit EMEA/MRL/693/99-FINAL October 1999 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS MARBOFLOXACIN

More information

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee VICH GL27 (ANTIMICROBIAL RESISTANCE: PRE-APPROVAL) December 2003 For implementation at Step 7 - Final GUIDANCE ON PRE-APPROVAL INFORMATION FOR REGISTRATION OF NEW VETERINARY MEDICINAL PRODUCTS FOR FOOD

More information

DETERMINATION OF ACTIVE SUBSTANCES IN MULTICOMPONENT VETERINARY PREPARATIONS OF ANTIPARASITIC ACTION BY HPLC METHOD

DETERMINATION OF ACTIVE SUBSTANCES IN MULTICOMPONENT VETERINARY PREPARATIONS OF ANTIPARASITIC ACTION BY HPLC METHOD Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 67 No. 5 pp. 463ñ468, 2010 ISSN 0001-6837 Polish Pharmaceutical Society DETERMINATION OF ACTIVE SUBSTANCES IN MULTICOMPONENT VETERINARY PREPARATIONS OF

More information

Determination, Confirmation and Quantitation of Multi-Class Antibiotic Residues in Milk by UHPLC MS/MS

Determination, Confirmation and Quantitation of Multi-Class Antibiotic Residues in Milk by UHPLC MS/MS APPLICATION NOTE Liquid Chromatography/ Mass Spectrometry Authors: Avinash Dalmia PerkinElmer, Inc. Shelton, CT Determination, Confirmation and Quantitation of Multi-Class Antibiotic Residues in Milk by

More information

Should you have any questions, please contact Edith Chang, Ph.D., Senior Scientific Liaison ( or

Should you have any questions, please contact Edith Chang, Ph.D., Senior Scientific Liaison ( or Amlodipine and Tablets Type of Posting Posting Date Targeted Official Date Notice of Intent to Revise 26 Oct 2018 To Be Determined, Revision Bulletin Expert Committee Chemical Medicines Monographs 2 In

More information

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NUFLOR 300 mg/ml solution for injection for cattle and sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:

More information

DOSAGE FORMS AND STRENGTHS Otic Suspension: Each OTIPRIO vial contains 1 ml of 6% (60 mg/ml) ciprofloxacin otic suspension. (3)

DOSAGE FORMS AND STRENGTHS Otic Suspension: Each OTIPRIO vial contains 1 ml of 6% (60 mg/ml) ciprofloxacin otic suspension. (3) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OTIPRIO safely and effectively. See full prescribing information for OTIPRIO. OTIPRIO (ciprofloxacin

More information

HPLC method for simultaneous determination of Albendazole metabolites in plasma

HPLC method for simultaneous determination of Albendazole metabolites in plasma Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2014, 6(11): 860-865 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 HPLC method for simultaneous determination of

More information

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS 1.B. SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Lamox 800 mg/g powder for use in drinking water for chickens and pigs 2. QUALITATIVE

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Kelacyl 100 mg/ml, solution for injection for cattle and pigs (BG, CY, CZ, DE, EL, FR, HU, IE, IT, LT, PL, PT, RO, SK, UK)

More information

Veterinary Drug Detection in Pork and Milk

Veterinary Drug Detection in Pork and Milk Application Note Food Testing Veterinary Drug Detection in Pork and Milk Using an Ultivo LC/TQ with a standard ESI ion source Figure 1. Agilent Ultivo LC/TQ with ESI source. Author Theresa Sosienski Agilent

More information

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin

More information

SELECT NEWS. Florfenicol Monograph: Injectable Therapy for Cattle

SELECT NEWS. Florfenicol Monograph: Injectable Therapy for Cattle SELECT NEWS Florfenicol Monograph: Injectable Therapy for Cattle Did you know that? Florfenicol is one of the most powerful antibiotics currently available in veterinary medicine with one of the lowest

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DOXYPRIM 40% soluble powder 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Doxycycline hyclate 400.0 mg Excipients:

More information

Principles of Antimicrobial therapy

Principles of Antimicrobial therapy Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or

More information

Sensitive and selective analysis of fipronil residues in eggs using Thermo Scientific GC-MS/MS triple quadrupole technology

Sensitive and selective analysis of fipronil residues in eggs using Thermo Scientific GC-MS/MS triple quadrupole technology APPLICATION NOTE 10575 Sensitive and selective analysis of fipronil residues in eggs using Thermo Scientific GC-MS/MS triple quadrupole technology Authors Cristian Cojocariu, 1 Joachim Gummersbach, 2 and

More information

ANNEX III LABELLING AND PACKAGE LEAFLET

ANNEX III LABELLING AND PACKAGE LEAFLET ANNEX III LABELLING AND PACKAGE LEAFLET 1 A. LABELLING 2 PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE PACKAGE Card box and package leaflet for brown glass bottle (Type 1) 1. NAME OF THE

More information

choice The Rilexine Palatable Tablets First generation cephalosporin for skin infections Now registered for ONCE daily administration*

choice The Rilexine Palatable Tablets First generation cephalosporin for skin infections Now registered for ONCE daily administration* Virbac Dermatology Palatable Tablets The choice First generation cephalosporin for skin infections Now registered for ONCE daily administration* are only available under Veterinary Authorisation. www.virbac.co.nz

More information

Introduction to Pharmacokinetics and Pharmacodynamics

Introduction to Pharmacokinetics and Pharmacodynamics Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:

More information

P Senthil Kumar, A Arivuchelvan, A Jagadeeswaran, N Punniamurthy, P Selvaraj, PN Richard Jagatheesan and P Mekala

P Senthil Kumar, A Arivuchelvan, A Jagadeeswaran, N Punniamurthy, P Selvaraj, PN Richard Jagatheesan and P Mekala 2018; 7(4): 1003-1007 ISSN (E): 2277-7695 ISSN (P): 2349-8242 NAAS Rating: 5.03 TPI 2018; 7(4): 1003-1007 2018 TPI www.thepharmajournal.com Received: 21-02-2018 Accepted: 25-03-2018 P Senthil Kumar Department

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ENROXIL 100 mg/ml solution for injection for cattle and pigs (AT, IE, NL, UK) ENROXAL 100 mg/ml solution for injection for

More information

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ALISKIREN AND AMLODIPINE IN TABLET DOSAGE FORM

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ALISKIREN AND AMLODIPINE IN TABLET DOSAGE FORM Page288 Research Article Pharmaceutical Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ALISKIREN AND AMLODIPINE IN TABLET DOSAGE FORM Divya P, Aleti P, Venisetty

More information

INTRODUCTION TO WILDLIFE PHARMACOLOGY. Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre

INTRODUCTION TO WILDLIFE PHARMACOLOGY. Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre INTRODUCTION TO WILDLIFE PHARMACOLOGY Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre General Pharmacology Factors That Affect Drug Absorption The dosage form Blood supply to the area

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS Revised: May 2014 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrox Flavour 150 mg Tablets for dogs (United Kingdom, Austria, Belgium, Germany, Denmark, Greece, Ireland,

More information

MOXIFLOXACIN HYDROCHLORIDE (MOXIFLOXACINI HYDROCHLORIDUM) Draft proposal for The International Pharmacopoeia. (January 2018)

MOXIFLOXACIN HYDROCHLORIDE (MOXIFLOXACINI HYDROCHLORIDUM) Draft proposal for The International Pharmacopoeia. (January 2018) January 2018 DRAFT FOR COMMENT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 MOXIFLOXACIN HYDROCHLORIDE (MOXIFLOXACINI HYDROCHLORIDUM) Draft proposal

More information

BIOEQUIVALENCE STUDY ON TWO BRANDS OF 10% ENROFLOXACIN ORAL FORMULATIONS IN CHICKENS. * Corresponding author:

BIOEQUIVALENCE STUDY ON TWO BRANDS OF 10% ENROFLOXACIN ORAL FORMULATIONS IN CHICKENS. * Corresponding author: BIOEQUIVALENCE STUDY ON TWO BRANDS OF 10% ENROFLOXACIN ORAL FORMULATIONS IN CHICKENS GBERINDYER 1, F. A., WANNANG 2, N. N. and AKWUOBU 3, C. A. 1 Department of Veterinary Physiology and Pharmacology, University

More information

Screening 36 Veterinary Drugs in Animal Origin Food by LC/MS/MS Combined with Modified QuEChERS Method

Screening 36 Veterinary Drugs in Animal Origin Food by LC/MS/MS Combined with Modified QuEChERS Method Screening 36 Veterinary Drugs in Animal Origin Food by LC/MS/MS Combined with Modified QuEChERS Method Application Note Food Testing and Agriculture Authors Jin-Lan Sun, Chang Liu, Yue Song Agilent Technologies

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

Anaesthesia and Analgesia of fish

Anaesthesia and Analgesia of fish Anaesthesia and Analgesia of fish Dr Stewart Fielder Port Stephens Fisheries Institute Marine fish production and enhancement Plan of talk Who uses anaesthetics for fish Why anaesthetics are used When

More information

VALIDATED RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM IN BULK AND PHARMACEUTICAL FORMULATION

VALIDATED RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM IN BULK AND PHARMACEUTICAL FORMULATION INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article VALIDATED RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF AMLODIPINE BESYLATE AND ATORVASTATIN

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Enrotron 50 mg/ml Solution for injection for cattle, pigs, dogs and cats

SUMMARY OF PRODUCT CHARACTERISTICS. Enrotron 50 mg/ml Solution for injection for cattle, pigs, dogs and cats SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrotron 50 mg/ml Solution for injection for cattle, pigs, dogs and cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each

More information

A Unique Approach to Managing the Problem of Antibiotic Resistance

A Unique Approach to Managing the Problem of Antibiotic Resistance A Unique Approach to Managing the Problem of Antibiotic Resistance By: Heather Storteboom and Sung-Chul Kim Department of Civil and Environmental Engineering Colorado State University A Quick Review The

More information

Pierre-Louis Toutain, Ecole Nationale Vétérinaire National veterinary School of Toulouse, France Wuhan 12/10/2015

Pierre-Louis Toutain, Ecole Nationale Vétérinaire National veterinary School of Toulouse, France Wuhan 12/10/2015 Antimicrobial susceptibility testing for amoxicillin in pigs: the setting of the PK/PD cutoff value using population kinetic and Monte Carlo Simulation Pierre-Louis Toutain, Ecole Nationale Vétérinaire

More information

Antibiotics use and Considerations: Calves and Heifers CLASSIFICATION OF CALVES. Danielle A. Mzyk TITLE 24 PT. ARIAL BOLD ALL CAPS

Antibiotics use and Considerations: Calves and Heifers CLASSIFICATION OF CALVES. Danielle A. Mzyk TITLE 24 PT. ARIAL BOLD ALL CAPS CALF AND HEIFER CONGRESS - 2016 Antibiotics use and Considerations: Calves and Heifers Danielle A. Mzyk TITLE 24 PT. ARIAL BOLD ALL CAPS Today s Presentation Classification of Calves Define Preruminant

More information

Use of Antibiotics in Ornamental Fish Aquaculture 1

Use of Antibiotics in Ornamental Fish Aquaculture 1 Cir 84 1 Roy P. E. Yanong 2 Introduction Antibiotics are very useful additions to any fish-health manager s toolbox, but they are only tools and not magic bullets. The ability of antibiotics to help eliminate

More information

Pharma Research Library. 2013, Vol. 1(1):19-29

Pharma Research Library. 2013, Vol. 1(1):19-29 Available online at www.pharmaresearchlibrary.com Pharma Research Library International Journal of Current Trends in Pharmaceutical Research 2013, Vol. 1(1):19-29 Pharma Research Library Method development

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12 1. NAME OF THE VETERINARY MEDICINAL PRODUCT HALOCUR 0.5 mg/ml oral solution for calves 2. Qualitative and quantitative composition Active substance Halofuginone

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Selectan 300 mg/ml solution for injection for cattle and swine. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:

More information

Determination of ofloxacin in bulk drug and pharmaceutical dosage form by high performance liquid chromatography method

Determination of ofloxacin in bulk drug and pharmaceutical dosage form by high performance liquid chromatography method Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (10):188-192 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker

Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker Richa Sah* and Saahil Arora 1. ISF College of Pharmacy, Moga, Punjab, India

More information

Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. BAYER HEALTHCARE LLC Animal Health Division USA Product Label http://www.vetdepot.com P.O. BOX 390, SHAWNEE MISSION, KS, 66201 0390 Customer Service Tel.: 800 633 3796 Customer Service Fax: 800 344 4219

More information

Analysis of Multiclass Veterinary Drugs in Baby Food by Ultra Fast Chromatography with High Performance Triple Quadrupole Mass Spectrometry

Analysis of Multiclass Veterinary Drugs in Baby Food by Ultra Fast Chromatography with High Performance Triple Quadrupole Mass Spectrometry Analysis of Multiclass Veterinary Drugs in Baby Food by Ultra Fast Chromatography with High Performance Triple Quadrupole Mass Spectrometry Charles Yang, 1 Dipankar Ghosh, 1 Mary Blackburn, 1 Jamie Humphries

More information